COVID-19: molecular targets, drug repurposing and new avenues for drug discovery

Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious infection that may break the healthcare system of several countries. Here, we aimed at presenting a critical view of ongoing drug repurposing efforts for COVID-19 as...

Descripción completa

Detalles Bibliográficos
Autores principales: Senger, Mario Roberto, Evangelista, Tereza Cristina Santos, Dantas, Rafael Ferreira, Santana, Marcos Vinicius da Silva, Gonçalves, Luiz Carlos Saramago, de Souza Neto, Lauro Ribeiro, Ferreira, Sabrina Baptista, Silva-Junior, Floriano Paes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534958/
https://www.ncbi.nlm.nih.gov/pubmed/33027420
http://dx.doi.org/10.1590/0074-02760200254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534958/
https://www.ncbi.nlm.nih.gov/pubmed/33027420
http://dx.doi.org/10.1590/0074-02760200254

Ejemplares similares